Searched for
COVID RNA THERAPY
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- COVID-19 vaccines may help some cancer patients fight tumorsNew research suggests COVID-19 mRNA vaccines could help cancer patients. Those with advanced lung or skin cancer who received Pfizer or Mod...
- Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccineRussia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...
- Cancer cure found? Scientists create a new mRNA vaccine that triggers strong anticancer immune response against tumoursUniversity of Florida scientists have engineered an experimental mRNA vaccine that stimulates the immune system to combat tumors in conjunc...
- Covid-19's surprising link to Cancer treatment: New study shows tumour shrinkage potentialResearchers have discovered that the Covid-19 virus may hold unexpected benefits for cancer treatment. The virus triggers the formation of ...
- New cancer vaccine that trains body's immune system to destroy cancer cells shows promising resultsCancer Vaccine: A new mRNA cancer vaccine developed by Moderna has shown promising early results in clinical trials. The vaccine, mRNA-4359...
- Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...
- Good mRNA! A Nobel breakthrough storyImmunologist Drew Weissman and biochemist Katalin Kariko have been awarded the 2023 Nobel Prize in Physiology or Medicine for their discove...
- Cancer vaccines are being developed using tech similar to that used for Covid shotsDecades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.
- Countries which chose Covishield fared better than those that took mRNA vax: Adar PoonawallaCovovax, which is our Novavax product, is proven to be the best against Omicron and Omicron sub variants. It is also the only vaccine from ...
- RNA-based therapy can protect from many Covid variants: StudyResearchers at Yale School of Medicine in the US noted that the molecule could lead to new treatments for COVID-19 in immunocompromised pat...
- Scientists developing chewing gum that could reduce SARS-CoV-2 transmissionIncubating samples obtained from nasopharyngeal swabs from Covid-positive patients with the gum, they showed that the ACE2 present could ne...
- Seeing good demand for biologics manufacturing: Syngene CEO Jonathan HuntIn an interview to ET, Jonathan Hunt, CEO and MD of Syngene said the company has spare capacity and is also investing on expansion of micro...
- AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugsVaxEquity, a startup founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are met, in a...
- A cure for cancer: After Covid vaccine, next mRNA miracle might be closer than you imagineThe new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...
- Indian scientists developing mRNA vaccine get funding from Ignite LSFThe three-year grant will fund research to develop the platform technologies for mRNA vaccine development including for the new variants of...
- Real-Life vaccination as clinical trialsAcross the world, Covid-19 vaccines have been given emergency approvals. Basically, long and protracted trials that vaccines developers ord...
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
- Mildly ill COVID-19 patients might be discharged in nine or more days after symptom onset: StudyScientists have assessed respiratory samples from 35 COVID-19 patients, and found that contagious coronavirus was "rarely detectable" beyon...
Load More
